We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy

Unwrap our new Directory

Metastasis

Bio-Pharma

Amplia Therapeutics Reports Promising Preclinical Narmafotinib Data in Pancreatic Cancer

MELBOURNE, Australia, July 30, 2026 Amplia Therapeutics announced the online publication of comprehensive preclinical findings evaluating narmafotinib in pancreatic...

By cGxPwire Editor
August 1, 2026

Recent Posts

01

Bio-Pharma

Satellite Bio Receives FDA Rare Pediatric Disease Designation for SB-101
August 5, 2026
02

MedTech

Aqua Medical Appoints Bob Haggerty to Lead Diabetes Growth
August 5, 2026
03

Bio-Pharma

Rhythm Pharmaceuticals Advances RM-718 with Promising Phase 2 Obesity Trial Results
August 5, 2026
04

Bio-Pharma

Harmony Biosciences Reports Record Q2 2026 Revenue, Shares Positive BP-205 Phase 1 Data
August 5, 2026
05

MedTech

Galaxy Therapeutics Secures CE Mark for SEAL System
August 5, 2026